CHROMADEX CORPORATION AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTEmployment Agreement • December 21st, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
This Amendment to Executive Employment Agreement (this “Amendment”), amending that certain Executive Employment Agreement dated March 12, 2017 (the “Employment Agreement”), by and between ChromaDex Corporation, a Delaware corporation (the “Company”), and Robert Fried (the “Executive”), is entered into as of December 20, 2017 by and among the Company and the Executive. Capitalized terms used herein which are not defined herein shall have the definition ascribed to them in the Employment Agreement.
Transition and Separation AgreementChromaDex Corp. • December 21st, 2017 • Medicinal chemicals & botanical products • California
This letter sets forth the terms and conditions of our agreement (“Agreement”) regarding the separation of your employment with ChromaDex Corporation and its subsidiaries, including Chromadex, Inc. (collectively, the “Company”), and the transition services you will provide. This Agreement will become effective on the Effective Date as defined in Section 10 herein. Capitalized terms that are used in this Agreement, but not defined herein, shall have the meanings ascribed to them in the Amended and Restated Employment Agreement between you and the Company, dated April 10, 2010 (the “Employment Agreement”).
